Zobrazeno 1 - 10
of 41
pro vyhledávání: '"D, Misailidou"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ignace Vergote, G Makedos, A. Makedos, Ioannis Kalogiannidis, Michalis Goutzioulis, Alexios Papanikolaou, D Misailidou
Publikováno v:
Archives of Gynecology and Obstetrics. 274:91-96
The purpose of the study is to evaluate whether surgery followed by radiotherapy in high-risk patients of early stage endometrial cancer can be replaced by formal surgical staging. Cancer-related survival and recurrence-free survival (RFS) were the e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c20ff9114313763332752230be56231
https://doi.org/10.1007/s00404-006-0138-y
https://doi.org/10.1007/s00404-006-0138-y
Autor:
P, Kosmidis, G, Fountzilas, S, Baka, E, Samantas, A M, Dimopoulos, H, Gogas, D, Skarlos, P, Papacostas, J, Boukovinas, Ch, Bakogiannis, P, Pantelakos, H, Athanasiou, D, Misailidou, P, Tsekeris, N, Pavlidis
Publikováno v:
Anticancer research. 27(6C)
Concurrent chemoradiotherapy has become a standard therapy for locoregionally advanced inoperable nonsmall cell lung cancer (NSCLC). The purpose of this phase II trial was to evaluate the efficacy and toxicity of concurrent chemoradiotherapy followin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b50092d0da81bcd5c1d184ded356aebb
https://pubmed.ncbi.nlm.nih.gov/18214050
https://pubmed.ncbi.nlm.nih.gov/18214050
Autor:
A, Papanikolaou, I, Kalogiannidis, D, Misailidou, M, Goutzioulis, P, Stamatopoulos, A, Makedos, A, Vatopoulou, G, Makedos
Publikováno v:
European journal of gynaecological oncology. 27(6)
The aim of the study is to present our experience in the treatment of uterine cervix cancer over the last decade. This is a retrospective study of 90 patients with cervical cancer treated in a University Department of Obstetrics and Gynecology from 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cc22fd9d8a4a5b3f2cf517a5f85cd5e6
https://pubmed.ncbi.nlm.nih.gov/17290593
https://pubmed.ncbi.nlm.nih.gov/17290593
Autor:
V. Papadopoulos, P. Varveris, N. Coliarakis, P. Karageorgis, D. Antonadou, M. Paraskevaidis, D. Misailidou, J. Skarlatos, C. Beroukas, H. Athanasiou, C. Kyprianou, G. Georgakopoulos
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 63:S82-S83
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a5d43101e2dccd260db0b85ad377ac64
https://doi.org/10.1016/j.ijrobp.2005.07.142
https://doi.org/10.1016/j.ijrobp.2005.07.142
Autor:
C. Kodona, D. Misailidou, M. Efstathiou, K. Hatziioannou, V. Giannouzakos, O. Kimoundri, P. Papavasileiou
Publikováno v:
Radiotherapy and Oncology. 76:S161-S162
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a54a86f682713c08d55d86ae572ac2e5
https://doi.org/10.1016/s0167-8140(05)81336-2
https://doi.org/10.1016/s0167-8140(05)81336-2
Autor:
D. Misailidou, M. Synodinou, D. Antonadou, P. Karageorgis, H. Athanassiou, E. Maragoudakis, K. Beroukas, G. Sarris, C. Verigos, M. Paraskevaidis
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 60:S162-S163
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::354ac22f74f0c5624af9173e6043ebcc
https://doi.org/10.1016/j.ijrobp.2004.06.082
https://doi.org/10.1016/j.ijrobp.2004.06.082
Autor:
Amanda Psyrri, G. Fountzilas, Sofia Lampaki, Despina Televantou, Vasiliki Kotoula, Kostas N. Syrigos, X. Mavropoulou, D. Misailidou, Dimitrios Pectasides
Publikováno v:
Cancer Research. 70:2710-2710
The anti-EGFR antibody cetuximab (Erbitux®, CTX) has been introduced into clinical practice for the treatment of SCCHN, as yet with modest effectiveness. Src family targeting agents have shown anti-growth activity in SCCHN preclinical models and are
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::27bb285605f1741baa058803ad20bc27
https://doi.org/10.1158/1538-7445.am10-2710
https://doi.org/10.1158/1538-7445.am10-2710
Autor:
P. Varveris, C. Kyprianou, P. Karageorgis, A. Panousaki, J. Skarlatos, D. Misailidou, V. Papadopoulos, G. Georgakopoulos, C. Beroukas, H. Athanasiou, D. Antonadou
Publikováno v:
Journal of Clinical Oncology. 24:18531-18531
18531 Background: Anaemia is a poor prognostic factor for patients undergoing radiotherapy (XRT) and has been associated with decreased response to treatment. Darbepoetin alfa has been proven effective in treating anaemia and in improving QoL. The pu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ccbbc9cec9faaad1cfcd541278ab932
https://doi.org/10.1200/jco.2006.24.18_suppl.18531
https://doi.org/10.1200/jco.2006.24.18_suppl.18531
Autor:
H. Athanassiou, N. Coliarakis, P. Karageorgis, D. Antonadou, D. Misailidou, M. Paraskevaidis, M. Synodinou-Menegaki, K. Chrysanthou, K. Kyprianou, G. Sarris
Publikováno v:
European Journal of Cancer Supplements. 1:S36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b9c0d8a3a5081647fe5d61145201ac40
https://doi.org/10.1016/s1359-6349(03)90136-4
https://doi.org/10.1016/s1359-6349(03)90136-4